The first in Russia research medical oncological cluster was created on the basis of the three leading medical centers in 2014. It is named The FSBI NMRRC (The Federal State Budgetary Institution National Medical Research Radiological Center) of the Ministry of Health of the Russian Federation. The cluster incorporates: P. Hertsen Moscow Oncology Research Center, A. Tsyb Medical Radiological Research Center and N. Lopatkin Research Institute of Urology and Interventional Radiology.
Our objective is to join the efforts of researchers and practitioners in combating cancer, create the conditions for introducing state-of-the-art technologies to treat cancer, and ensure a breakthrough of Russian science and medical practice in the area of nuclear medicine. Thanks to merging the capacities of the institutes which became the branches of the FSBI NMRRC of the Ministry of Health the Russian Federation, domestic oncologists now have a real opportunity to reach world leaders in this field.
The oncology cluster is headed by Professor A. Kaprin, corresponding member of the Russian Academy of Sciences, Director of P. Hertsen Moscow Oncology Research Center who is now also Director General of the FSBI NMRRC of the Ministry of Health of the Russian Federation. Professor A. Kaprin is now holding the both managerial positions, while P.Hertsen Moscow Oncology Research Center has become a branch of the the FSBI NMRRC.
Built in 1898 on donations of Moscow merchants, the Center has become the oldest scientific and practical institution in Europe and the first cancer hospital in Russia, where the basics of the Russian oncological science and service were laid. The Center has created a scientific and clinical school which has trained many of today's leading oncologists of Russia and other countries. Among the Center’s staff were academicians of the Russian Academy of Sciences A.I. Abrikosov and B.V. Petrovsky; corresponding members of the Russian Academy of Sciences P.A. Hertsen, N.N. Petrov; academicians of the Russian Academy of Medical Sciences S.S. Debov, B.I. Zbarsky, L.A. Zilber, A.S. Zilber, A.S. Pavlov, A.I. Savitsky, L.M. Shabad; corresponding members of the Russian Academy of Medical Sciences L.N. Novikov, B.V. Ognev, B.E. Peterson and many other outstanding scientists who at different times made a significant contribution to the development of oncology in Russia.
From 1922 to 1933 the Center was headed by P.A. Hertsen, an outstanding scientist and surgeon, founder of the Moscow school of oncology. For his significant contribution to the development of the Center and of oncological science in Russia the Central Research Oncology Center of the RSFSR People's Commissariat was named after P.A. Hertsen in 1947. Between 1982 and 2013 the Center was headed by Academician of the Russian Academy of Medical Sciences, Professor V.I. Chissov. Since 2013 till present the Director of the Center is the corresponding member of Russian Academy of Sciences, Professor Andrei Dmitrievich Kaprin.
In 2014 the Center became a branch in the Federal State Budgetary Institution “National Medical Research Radiological Center” of the Ministry of Health of the Russian Federation, and Professor Kaprin was appointed Director General of the FSBI NMRRC of the Ministry of Health of the Russian Federation.
The top scientific developments of the Center:
P. Hertsen Research Center has introduced the state-of-the-art methods of complex treatment and diagnosis of cancer with such devices as cyber knife and others.
The Center is the leading oncological institution of the Ministry of Health of the Russian Federation. It keeps the integrated Russian National Cancer Register.
It was founded in 1962 as the Institute of Medical Radiology of the Academy of Medical Sciences of the USSR to develop and improve methods of radiation diagnostics and therapy, to prevent and treat radiation injuries, as well as to study biological and medical effects of ionizing radiation.
The Center is the major institution in the area of “Medical Radiology and Radiation Medicine”, a leading institution in the Russian Federation on the development and application of high-tech medicine, radiology diagnosis and treatment of patients with cancer and non-cancer diseases.
The main activity areas of the Center
Clinical Radiology sector
The departments of the Clinical Radiology sector provide high-level diagnostic, counseling and medical assistance to patients with oncological and somatic diseases.
The Center has successfully put into practice various technologies of conformal rdiotherapy therapy (3D, IMRT, IGRT) and non-conventional techniques of distant photon therapy, including the combination of the latter with local hyperthermia. The Center's experts have also accumulated a vast experience in application of such a high-tech method of treating malignant neoplasms as intra-operative beam therapy. The center uses techniques of interstitial radiation therapy, including brachytherapy of prostate cancer and of tumors of the oral cavity.
The technique of radioiodine therapy is used for patients with thyroid cancer and thyrotoxicosis. In case of bone metastases radionuclide therapy is applied.
Methods of photodynamic therapy have been widely used in the Center due to their low invasiveness, selective tissue destruction and the possibility of repeated use, as well as good cosmetic results and the absence of toxic immunosuppressive reactions.
The FSBI Institute of Urology of the Ministry of Health of Russia was established in 1979 on the basis of the fundamental research uronephrology laboratory at the N. Pirogov 2nd Moscow Medical Institute. The history of the Institute is inseparable from the name of Nikolai Lopatkin, Professor and Academician of the Russian Academy of Medical Sciences, who headed the Department of Urology and Surgical Nephrology, and later became the Director of the N. Pirogov Russian National Research Medical University.
The Institute is engaged in introduction of innovative and the most promising treatment technologies in daily practice of a urology hospital. Russia's first operation of brachytherapy for prostate cancer was carried out in the Institute of Urology. The Institute’s staff is in the forefront of the use of cryoablation for prostate cancer and renal tumors, photodynamic diagnosis and treatment of bladder cancer. Research is underway to develop unique panels promising markers for bladder cancer and prostate cancer, accurate diagnostic methods for prostate cancer and the treatment of organ. The Institute is also carrying out clinical trials of new anticancer drugs in the framework of international protocols.